{"nct_id":"NCT03410108","title":"Phase 2 Study of Brigatinib in Japanese Participants With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC)","status":"COMPLETED","status_verified_date":"2022-06","start_date":"2018-01-29","start_date_type":"ACTUAL","primary_completion_date":"2020-09-29","primary_completion_date_type":"ACTUAL","completion_date":"2021-07-28","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TAK"]}